This announcement is a separate document:
健友股份关于获得国家药品监督管理局瑞加诺生注射液药品注册批件的公告
Announcement from Nanjing King-Friend Biochemical Pharmaceutical on obtaining the registration certificate for Ruijiaenosine injection from the National Medical Products Administration.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.